Objective
Transposable elements (TEs) account for more than two thirds of the human genome. They can inactivate
genes, provide novel coding functions, sprinkle chromosomes with recombination-prone repetitive
sequences, and modulate cellular gene expression through a wide variety of transcriptional and
posttranscriptional influences. As a consequence, TEs are considered as essential motors of evolution yet
they are occasionally associated with disease, causing about one hundred Mendelian disorders and possibly
contributing to several human cancers. As expected for such genomic threats, TEs are subjected to tight
epigenetic control imposed from the very first days of embryogenesis, in part owing to their recognition by
sequence-specific RNA- and protein-based repressors. It is generally considered that the evolutionary
selection of these TE controllers reflects a simple host-pathogen arms race, and that their action results in the
early and permanent silencing of their targets. We have recently uncovered new evolutionary evidence and
obtained genomic and functional data that invalidate this dual assumption, and suggest instead that
transposable elements and their epigenetic controllers establish species-specific transcriptional networks that
play critical roles in human development and physiology. The general objective of the present proposal is to
explore the breadth of this phenomenon, to decipher its mechanisms, to unveil its functional implications,
and to probe how this knowledge could be exploited for basic research, biotechnology and clinical medicine.
Fields of science
Programme(s)
Topic(s)
Funding Scheme
ERC-ADG - Advanced GrantHost institution
1015 Lausanne
Switzerland